Unhealthy Pharmaceutical Regulation: Innovation, Politics and Promissory Science

Hardcover | November 8, 2013

byJohn Abraham, Courtney Davis

not yet rated|write a review
European and American drug regulators govern a multi-billion-dollar pharmaceutical industry selling its products on the world's two largest medicines markets. This is the first book to investigate how effectively American and supranational EU governments have regulated innovative pharmaceuticals regarding public health during the neo-liberal era of the last 30 years. Drawing on years of fieldwork, the authors demonstrate that pharmaceutical regulation and innovation have been misdirected by commercial interests and misconceived ideologies, which induced a deregulatory political culture contrary to health interests. They dismantle the myth that pharmaceutical innovations necessarily equate with therapeutic advances and explain how it has been perpetuated in the interests of industry by corporate bias within the regulatory state, unwarranted expectations of promissory science, and the emergent patient-industry complex. Endemic across both continents, the misadventures of pharmaceutical deregulation are shown to span many therapeutic areas, including cancer, diabetes and irritable bowel syndrome. The authors propose political changes needed to redirect pharmaceutical regulation in the interests of health.

Pricing and Purchase Info

$149.49 online
$149.50 list price
In stock online
Ships free on orders over $25

From the Publisher

European and American drug regulators govern a multi-billion-dollar pharmaceutical industry selling its products on the world's two largest medicines markets. This is the first book to investigate how effectively American and supranational EU governments have regulated innovative pharmaceuticals regarding public health during the neo-l...

Courtney Davis is Senior Lecturer in Sociology at Kings College London, UK. Previously Director of the Centre for Corporate Accountability, she is author of Making Companies Safe. John Abraham is Professor of Sociology at Kings College London, UK. Author of over 100 publications on pharmaceuticals in society, he was Special Expert Adv...

other books by John Abraham

Advances in Heat Transfer
Advances in Heat Transfer

Kobo ebook|Oct 27 2015

$240.00

Beyond the Wall: Exploring George R. R. Martin's A Song of Ice and Fire, From A Game of Thrones to…
Beyond the Wall: Exploring George R. R. Martin's A Song...

Kobo ebook|Jun 26 2012

$16.19 online$20.99list price(save 22%)
The African Christian and Islam
The African Christian and Islam

Kobo ebook|Sep 2 2016

$20.19 online$26.23list price(save 23%)
see all books by John Abraham
Format:HardcoverDimensions:336 pages, 11.12 × 5.69 × 0.78 inPublished:November 8, 2013Publisher:Palgrave MacmillanLanguage:English

The following ISBNs are associated with this title:

ISBN - 10:0230008666

ISBN - 13:9780230008663

Look for similar items by category:

Customer Reviews of Unhealthy Pharmaceutical Regulation: Innovation, Politics and Promissory Science

Reviews

Extra Content

Table of Contents

1. Putting Pharmaceutical Regulation to the Test: A Social Science for Public Health

2. The Political Economy of 'Innovative' Drug Regulation in the Neo-Liberal Era

3. Designs on Diabetes Drugs

4. Desperate Regulation for Desperate Cancer Patients

5. The Making of a Harmful 'Therapeutic Breakthrough'

6. The Regulatory Science and Politics of Risk Management

7. Conclusions and Policy Implications